{ "company_number": "10990644", "name": "Verbatim Pharma Ltd", "url": "/company/10990644", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2017-10-02", "dissolved_on": null, "sic_codes": [ { "code": "78109", "description": "Other activities of employment placement agencies", "section": "N", "section_name": "Administrative and support service activities", "url": "/sic/78109" }, { "code": "78300", "description": "Human resources provision and management of human resources functions", "section": "N", "section_name": "Administrative and support service activities", "url": "/sic/78300" } ], "registered_address": { "id": 2856077, "url": "/address/2856077", "line1": "SUITE 4 AMERSHAM HOUSE", "line2": "MILL STREET", "post_town": "BERKHAMSTED", "county": "HERTFORDSHIRE", "country": "ENGLAND", "postcode": "HP4 2DT" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/10990644", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-09-30", "last_made_up": "2024-12-31", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/10990644/accounts/2024-12-31", "pdf_url": "/company/10990644/accounts/2024-12-31.pdf", "made_up_date": "2024-12-31", "period_start": "2024-12-31", "period_end": "2024-12-31", "entity_name": "Verbatim Pharma Ltd", "dormant": false, "average_employees": "12.00", "tangible_fixed_assets": "92829.00", "debtors": "363265.00", "cash_bank_in_hand": "222164.00", "current_assets": "585429.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "481135.00", "total_assets_less_current_liabilities": "573964.00", "net_assets_liabilities": "550757.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "550657.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-July2025.zip" }, { "url": "/company/10990644/accounts/2023-12-31", "pdf_url": "/company/10990644/accounts/2023-12-31.pdf", "made_up_date": "2023-12-31", "period_start": "2023-12-31", "period_end": "2023-12-31", "entity_name": "Verbatim Pharma Ltd", "dormant": false, "average_employees": "9.00", "tangible_fixed_assets": "119049.00", "debtors": "250168.00", "cash_bank_in_hand": "366220.00", "current_assets": "616388.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "556015.00", "total_assets_less_current_liabilities": "675064.00", "net_assets_liabilities": "666802.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "666702.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2024.zip" }, { "url": "/company/10990644/accounts/2022-10-31", "pdf_url": "/company/10990644/accounts/2022-10-31.pdf", "made_up_date": "2022-10-31", "period_start": "2022-10-31", "period_end": "2022-10-31", "entity_name": "Verbatim Pharma Ltd", "dormant": false, "average_employees": "8.00", "tangible_fixed_assets": "141733.00", "debtors": "378789.00", "cash_bank_in_hand": "652803.00", "current_assets": "1031592.00", "creditors_due_within_one_year": "78492.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "953100.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "1067904.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "1067804.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2023.zip" }, { "url": "/company/10990644/accounts/2021-10-31", "pdf_url": "/company/10990644/accounts/2021-10-31.pdf", "made_up_date": "2021-10-31", "period_start": "2021-10-31", "period_end": "2021-10-31", "entity_name": "Verbatim Pharma Ltd", "dormant": false, "average_employees": "7.00", "tangible_fixed_assets": "61276.00", "debtors": "613680.00", "cash_bank_in_hand": "723688.00", "current_assets": "1337368.00", "creditors_due_within_one_year": "239632.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1097736.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "1147369.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "1147269.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2022.zip" }, { "url": "/company/10990644/accounts/2020-10-31", "pdf_url": "/company/10990644/accounts/2020-10-31.pdf", "made_up_date": "2020-10-31", "period_start": "2020-10-31", "period_end": "2020-10-31", "entity_name": "Verbatim Pharma Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "2207.00", "debtors": "515996.00", "cash_bank_in_hand": "390292.00", "current_assets": "907838.00", "creditors_due_within_one_year": "243677.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "664161.00", "total_assets_less_current_liabilities": null, "net_assets_liabilities": "665948.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "665848.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2021.zip" }, { "url": "/company/10990644/accounts/2019-10-31", "pdf_url": "/company/10990644/accounts/2019-10-31.pdf", "made_up_date": "2019-10-31", "period_start": "2019-10-31", "period_end": "2019-10-31", "entity_name": "Verbatim Pharma Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "1583.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "214073.00", "creditors_due_within_one_year": "67044.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "147029.00", "total_assets_less_current_liabilities": "148612.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "148311.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2019.zip" }, { "url": "/company/10990644/accounts/2018-10-31", "pdf_url": "/company/10990644/accounts/2018-10-31.pdf", "made_up_date": "2018-10-31", "period_start": "2018-10-31", "period_end": "2018-10-31", "entity_name": "Verbatim Pharma Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "897.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "52604.00", "creditors_due_within_one_year": "21503.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "31101.00", "total_assets_less_current_liabilities": "31998.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "30998.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2019.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/10990644/filing-history" }, "confirmation_statement": { "next_due": "2027-06-11", "last_made_up": "2026-05-28" }, "officers": [ { "name": "MACKENZIE, Matthew", "person_url": "/person/5538850", "role": "director", "appointed_on": "2019-04-03", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-07-08T17:14:18+00:00" }, { "name": "RAMTOOLAH, Jasmine", "person_url": "/person/5538811", "role": "director", "appointed_on": "2017-10-02", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-07-08T17:14:18+00:00" } ], "psc": [ { "name": "Mr Matthew Mackenzie", "kind": "individual-person-with-significant-control", "person_url": "/person/3242642", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2022-05-29", "ceased_on": "2023-09-30", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mrs Jasmine Ramtoolah", "kind": "individual-person-with-significant-control", "person_url": "/person/2212146", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-50-to-75-percent", "voting-rights-50-to-75-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2017-10-02", "ceased_on": "2023-09-30", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Verbatim Services Group Ltd", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/15033373", "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2023-09-30", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-29T21:09:53.382073+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }